Dr. Holly Pederson
Dr. Holly Pederson is an esteemed medical professional who holds the position of Director of the Medical Breast Program at the renowned Cleveland Clinic. Additionally, she serves as an Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. Dr. Pederson specializes in the management of patients with identified genetic mutations that predispose them to breast cancer, and she operates a Hereditary High-Risk Clinic dedicated to this purpose.
With a strong commitment to advancing medical knowledge, Dr. Pederson actively engages in clinical research. Her expertise is further validated by her Board Certification in Internal Medicine and her completion of a clinical genetics fellowship at the Cleveland Clinic in 2008. In 2017, she also successfully completed the City of Hope Intensive Course in Cancer Risk Assessment, further enhancing her capabilities in this field.
Recognized for her contributions, Dr. Pederson holds a significant role on the NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian Committee. Her academic journey includes obtaining an undergraduate degree in biochemistry from the esteemed University of California at Santa Barbara. Subsequently, she pursued her medical education and completed her internal medicine residency at the University of California, San Francisco, where she achieved the distinction of Alpha Omega Alpha.
In both her personal and professional pursuits, Dr. Pederson places great emphasis on wellness and prevention. She aspires to contribute to the national movement fostered by Breastcancer.org, which advocates for breast health, women's health, and overall well-being. Through her involvement with this organization, Dr. Pederson aims to ensure that individuals facing breast cancer receive the support and guidance they need so that no one has to endure this journey alone.